Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort

J Am Acad Dermatol. 2023 Apr;88(4):900-904. doi: 10.1016/j.jaad.2022.10.034. Epub 2022 Oct 21.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Janus Kinase 1
  • Janus Kinase Inhibitors* / therapeutic use
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Janus Kinase Inhibitors
  • Janus Kinase 1